APO Research
Talk to an analyst

APO RESEARCH · REPORT

Esketamine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Esketamine Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchEsketamine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Esketamine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Esketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esketamine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Esketamine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Esketamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Esketamine include Janssen Pharmaceutica, Merck, PFIZER, Medkoo and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Esketamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Esketamine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Esketamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Esketamine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Esketamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Esketamine Market by Company

Janssen Pharmaceutica

Merck

PFIZER

Medkoo

Endo International

Esketamine Segment by Type

Injection

Oral Medications

Nasal Spray

Esketamine Segment by Application

General Anesthetic

Treatment-resistant Depression

Esketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Esketamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Esketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Oral Medications Table 3. Major Company of Nasal Spray Table 4. Global Esketamine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Esketamine Sales by Type (2021-2026) & (k units) Table 6. Global Esketamine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Esketamine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Esketamine Sales Market Share in Value by Type (2021-2026) Table 9. Global Esketamine Price by Type (2021-2026) & (US$/unit) Table 10. Global Esketamine Sales by Type (2027-2032) & (k units) Table 11. Global Esketamine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Esketamine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Esketamine Sales Market Share in Value by Type (2027-2032) Table 14. Global Esketamine Price by Type (2027-2032) & (US$/unit) Table 15. North America Esketamine Sales by Type (2021-2026) & (k units) Table 16. North America Esketamine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Esketamine Sales by Type (2021-2026) & (k units) Table 18. Europe Esketamine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Esketamine Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Esketamine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Esketamine Sales by Type (2021-2026) & (k units) Table 22. Latin America Esketamine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Esketamine Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Esketamine Sales by Type (2021-2026) & (US$ Million) Table 25. Esketamine Industry Trends Table 26. Esketamine Industry Drivers Table 27. Esketamine Industry Opportunities and Challenges Table 28. Esketamine Industry Restraints Table 29. Global Esketamine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Esketamine Revenue Market Share by Company (2021-2026) Table 31. Global Esketamine Sales by Company (2021-2026) & (k units) Table 32. Global Esketamine Sales Share by Company (2021-2026) Table 33. Global Esketamine Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Esketamine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Esketamine Major Company Production Sites and Headquarters Table 36. Global Esketamine Company, Product Type & Application Table 37. Global Esketamine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Esketamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Esketamine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Esketamine Sales by Region (2021-2026) & (k units) Table 42. Global Esketamine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Esketamine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Esketamine Sales Market Share in Value by Region (2021-2026) Table 45. Global Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Esketamine Sales by Region (2027-2032) & (k units) Table 47. Global Esketamine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Esketamine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Esketamine Sales Market Share in Value by Region (2027-2032) Table 50. Global Esketamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Esketamine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Esketamine Sales by Application (2021-2026) & (k units) Table 53. Global Esketamine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Esketamine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Esketamine Sales Market Share in Value by Application (2021-2026) Table 56. Global Esketamine Price by Application (2021-2026) & (US$/unit) Table 57. Global Esketamine Sales by Application (2027-2032) & (k units) Table 58. Global Esketamine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Esketamine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Esketamine Sales Market Share in Value by Application (2027-2032) Table 61. Global Esketamine Price by Application (2027-2032) & (US$/unit) Table 62. North America Esketamine Sales by Application (2021-2026) & (k units) Table 63. North America Esketamine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Esketamine Sales by Application (2021-2026) & (k units) Table 65. Europe Esketamine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Esketamine Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Esketamine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Esketamine Sales by Application (2021-2026) & (k units) Table 69. Latin America Esketamine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Esketamine Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Esketamine Sales by Application (2021-2026) & (US$ Million) Table 72. Janssen Pharmaceutica Company Information Table 73. Janssen Pharmaceutica Business Overview Table 74. Janssen Pharmaceutica Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Janssen Pharmaceutica Esketamine Product Portfolio Table 76. Janssen Pharmaceutica Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Merck Esketamine Product Portfolio Table 81. Merck Recent Development Table 82. PFIZER Company Information Table 83. PFIZER Business Overview Table 84. PFIZER Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. PFIZER Esketamine Product Portfolio Table 86. PFIZER Recent Development Table 87. Medkoo Company Information Table 88. Medkoo Business Overview Table 89. Medkoo Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Medkoo Esketamine Product Portfolio Table 91. Medkoo Recent Development Table 92. Endo International Company Information Table 93. Endo International Business Overview Table 94. Endo International Esketamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Endo International Esketamine Product Portfolio Table 96. Endo International Recent Development Table 97. North America Esketamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 98. North America Esketamine Sales by Country (2021-2026) & (k units) Table 99. North America Esketamine Sales Market Share by Country (2021-2026) Table 100. North America Esketamine Sales Forecast by Country (2027-2032) & (k units) Table 101. North America Esketamine Sales Market Share Forecast by Country (2027-2032) Table 102. North America Esketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Esketamine Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Esketamine Market Share by Country (2021-2026) Table 105. North America Esketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Esketamine Market Share Forecast by Country (2027-2032) Table 107. Europe Esketamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. Europe Esketamine Sales by Country (2021-2026) & (k units) Table 109. Europe Esketamine Sales Market Share by Country (2021-2026) Table 110. Europe Esketamine Sales Forecast by Country (2027-2032) & (k units) Table 111. Europe Esketamine Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Esketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Esketamine Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Esketamine Market Share by Country (2021-2026) Table 115. Europe Esketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Esketamine Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Esketamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Esketamine Sales by Country (2021-2026) & (k units) Table 119. Asia-Pacific Esketamine Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Esketamine Sales Forecast by Country (2027-2032) & (k units) Table 121. Asia-Pacific Esketamine Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Esketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Esketamine Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Esketamine Market Share by Country (2021-2026) Table 125. Asia-Pacific Esketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Esketamine Market Share Forecast by Country (2027-2032) Table 127. Latin America Esketamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Latin America Esketamine Sales by Country (2021-2026) & (k units) Table 129. Latin America Esketamine Sales Market Share by Country (2021-2026) Table 130. Latin America Esketamine Sales Forecast by Country (2027-2032) & (k units) Table 131. Latin America Esketamine Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Esketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Esketamine Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Esketamine Market Share by Country (2021-2026) Table 135. Latin America Esketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Esketamine Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Esketamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Esketamine Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Esketamine Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Esketamine Sales Forecast by Country (2027-2032) & (k units) Table 141. Middle East and Africa Esketamine Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Esketamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Esketamine Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Esketamine Market Share by Country (2021-2026) Table 145. Middle East and Africa Esketamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Esketamine Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Esketamine Distributors List Table 150. Esketamine Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Esketamine Image Figure 2. Global Esketamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esketamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Esketamine Sales (2021-2032) & (k units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Medications Image Figure 8. Global Oral Medications Sales YoY Growth (2021-2032) & (k units) Figure 9. Nasal Spray Image Figure 10. Global Nasal Spray Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Esketamine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Esketamine Market Share by Type 2025 VS 2032 Figure 13. North America Esketamine Sales Market Share in Volume by Type in 2025 Figure 14. North America Esketamine Sales Market Share in Value by Type in 2025 Figure 15. Europe Esketamine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Esketamine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Esketamine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Esketamine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Esketamine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Esketamine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Esketamine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Esketamine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Esketamine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. General Anesthetic Image Figure 26. Global General Anesthetic Sales YoY Growth (2021-2032) & (k units) Figure 27. Treatment-resistant Depression Image Figure 28. Global Treatment-resistant Depression Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Esketamine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Esketamine Market Share by Application 2025 VS 2032 Figure 31. North America Esketamine Sales Market Share in Volume by Application in 2025 Figure 32. North America Esketamine Sales Market Share in Value by Application in 2025 Figure 33. Europe Esketamine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Esketamine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Esketamine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Esketamine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Esketamine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Esketamine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Esketamine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Esketamine Sales Market Share in Value by Application in 2025 Figure 41. North America Esketamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Esketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Esketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Esketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Esketamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Esketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Esketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Esketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Esketamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Esketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Esketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Esketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Esketamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Esketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Esketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Esketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Esketamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Esketamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Esketamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Esketamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Esketamine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Esketamine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Medications
  • Nasal Spray
Applications
  • General Anesthetic
  • Treatment-resistant Depression
Companies covered
  • Janssen Pharmaceutica
  • Merck
  • PFIZER
  • Medkoo
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Esketamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Esketamine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Esketamine Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Oral Medications
  8. 1.3.3 Nasal Spray
  9. 1.4 Global Esketamine Market Size by Type
  10. 1.4.1 Global Esketamine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Esketamine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Esketamine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Esketamine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Esketamine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Esketamine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Esketamine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Esketamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Esketamine Industry Trends
  2. 2.2 Esketamine Industry Drivers
  3. 2.3 Esketamine Industry Opportunities and Challenges
  4. 2.4 Esketamine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Esketamine Revenue (2021-2026)
  2. 3.2 Global Top Players by Esketamine Sales (2021-2026)
  3. 3.3 Global Top Players by Esketamine Price (2021-2026)
  4. 3.4 Global Esketamine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Esketamine Major Company Production Sites & Headquarters
  6. 3.6 Global Esketamine Company, Product Type & Application
  7. 3.7 Global Esketamine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Esketamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Esketamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Esketamine Tier 1, Tier 2, and Tier 3
4 Esketamine Regional Status and Outlook
  1. 4.1 Global Esketamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Esketamine Historic Market Size by Region
  3. 4.2.1 Global Esketamine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Esketamine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Esketamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Esketamine Forecasted Market Size by Region
  7. 4.3.1 Global Esketamine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Esketamine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Esketamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Esketamine by Application
  1. 5.1 Esketamine Market by Application
  2. 5.1.1 General Anesthetic
  3. 5.1.2 Treatment-resistant Depression
  4. 5.2 Global Esketamine Market Size by Application
  5. 5.2.1 Global Esketamine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Esketamine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Esketamine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Esketamine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Esketamine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Esketamine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Esketamine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Esketamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Pharmaceutica
  2. 6.1.1 Janssen Pharmaceutica Company Information
  3. 6.1.2 Janssen Pharmaceutica Business Overview
  4. 6.1.3 Janssen Pharmaceutica Esketamine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Pharmaceutica Esketamine Product Portfolio
  6. 6.1.5 Janssen Pharmaceutica Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Esketamine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Esketamine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 PFIZER
  14. 6.3.1 PFIZER Company Information
  15. 6.3.2 PFIZER Business Overview
  16. 6.3.3 PFIZER Esketamine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 PFIZER Esketamine Product Portfolio
  18. 6.3.5 PFIZER Recent Developments
  19. 6.4 Medkoo
  20. 6.4.1 Medkoo Company Information
  21. 6.4.2 Medkoo Business Overview
  22. 6.4.3 Medkoo Esketamine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Medkoo Esketamine Product Portfolio
  24. 6.4.5 Medkoo Recent Developments
  25. 6.5 Endo International
  26. 6.5.1 Endo International Company Information
  27. 6.5.2 Endo International Business Overview
  28. 6.5.3 Endo International Esketamine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Endo International Esketamine Product Portfolio
  30. 6.5.5 Endo International Recent Developments
7 North America by Country
  1. 7.1 North America Esketamine Sales by Country
  2. 7.1.1 North America Esketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Esketamine Sales by Country (2021-2026)
  4. 7.1.3 North America Esketamine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Esketamine Market Size by Country
  6. 7.2.1 North America Esketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Esketamine Market Size by Country (2021-2026)
  8. 7.2.3 North America Esketamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Esketamine Sales by Country
  2. 8.1.1 Europe Esketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Esketamine Sales by Country (2021-2026)
  4. 8.1.3 Europe Esketamine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Esketamine Market Size by Country
  6. 8.2.1 Europe Esketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Esketamine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Esketamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Esketamine Sales by Country
  2. 9.1.1 Asia-Pacific Esketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Esketamine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Esketamine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Esketamine Market Size by Country
  6. 9.2.1 Asia-Pacific Esketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Esketamine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Esketamine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Esketamine Sales by Country
  2. 10.1.1 South America Esketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Esketamine Sales by Country (2021-2026)
  4. 10.1.3 South America Esketamine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Esketamine Market Size by Country
  6. 10.2.1 South America Esketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Esketamine Market Size by Country (2021-2026)
  8. 10.2.3 South America Esketamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Esketamine Sales by Country
  2. 11.1.1 Middle East and Africa Esketamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Esketamine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Esketamine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Esketamine Market Size by Country
  6. 11.2.1 Middle East and Africa Esketamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Esketamine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Esketamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Esketamine Value Chain Analysis
  2. 12.1.1 Esketamine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Esketamine Production Mode & Process
  7. 12.2 Esketamine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Esketamine Distributors
  10. 12.2.3 Esketamine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst